Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine Combination for Epidural Labor Analgesia and Neonatal Outcomes: a Pilot Randomized Trial
Phase: PHASE4 | Sponsor: Peking University First Hospital | Compound: Ketamine
- Status
- planned
- Institution
- Peking University First Hospital
- Start date
- 2025-08-01
- End date
- 2026-10-01
- Registry ID
- NCT07145775
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.